From: A comparison of Chinese and non-Chinese Canadian patients hospitalized with heart failure
Chinese (n = 1,004) | Non-Chinese (n = 73,708) | P | |
---|---|---|---|
Medications prescribed (%) | |||
ACE inhibitors | 57.5 | 66.4 | <0.001 |
ARBs | 17.4 | 8.9 | <0.001 |
ARBs and ACE inhibitors | 6.1 | 2.9 | <0.001 |
ARBs or ACE inhibitors | 68.8 | 72.4 | 0.011 |
Amiodarone | 9.1 | 8.3 | 0.37 |
Beta-blockers | 42.5 | 41.6 | 0.54 |
Calcium channel blockers, 1st generation | 14.9 | 14.2 | 0.48 |
Calcium channel blockers, 2nd generation | 21.6 | 15.3 | <0.001 |
COX-2 inhibitors | 3.2 | 2.8 | 0.48 |
Digoxin | 29.4 | 36.1 | <0.001 |
Furosemide | 81.5 | 85.6 | <0.001 |
NSAIDs (excluding COX-2 inhibitors) | 5.0 | 5.7 | 0.36 |
Spironolactone | 12.6 | 15.0 | 0.033 |
Statins | 27.6 | 25.9 | 0.22 |
Vasodilators | 42.6 | 42.9 | 0.87 |
Warfarin | 27.6 | 28.3 | 0.62 |